Blocking KDM5A/B boosts antitumor immune responses in HHV-8-positive B-cell lymphomas
Zhou, Fiches, Wu and colleagues report that blocking the chromatin-regulating enzymes KDM5A and KDM5B can strengthen antitumor innate immune responses ...
Zhou, Fiches, Wu and colleagues report that blocking the chromatin-regulating enzymes KDM5A and KDM5B can strengthen antitumor innate immune responses ...
Irvine, Calif., Aug. 20, 2026 — Immunotherapy has changed the outlook for many people with advanced cancer by turning the ...
Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy have identified a potential way ...
Colorectal cancer has become a proving ground for a new generation of cancer treatments, but one of the most promising ...
For years, CAR-T cell therapy has stood as one of cancer medicine’s most striking successes. By removing a patient’s T ...
Personalized cancer vaccines are moving from an experimental promise toward a more structured form of immunotherapy, but the field still ...
Cancer researchers have reported a new strategy that combines bacterial tumor targeting, nutrient deprivation and immune stimulation in a single ...
Cancer immunotherapy has transformed treatment for some patients, yet many solid tumors remain protected by a hostile biological environment that ...
Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...
Cancer researchers have designed a synthetic peptide that turns tumour cells into highly visible targets for the immune system by ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine